Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis

BACKGROUND: Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on he...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Indian Pacing Electrophysiol J
Asıl Yazarlar: Murtaza, Ghulam, Turagam, Mohit K., Garg, Jalaj, Boda, Urooge, Akella, Krishna, Velagapudi, Poonam, Natale, Andrea, Gopinathannair, Rakesh, Lakkireddy, Dhanunjaya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263313/
https://ncbi.nlm.nih.gov/pubmed/33866017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ipej.2021.04.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller